Biotech

All Articles

BioAge eyes $180M coming from IPO, exclusive positioning for excessive weight trials

.BioAge Labs is checking out about $180 thousand in first proceeds from an IPO and also a private po...

Merck's LAG-3 combination falls short colon cancer cells period 3 research

.A try through Merck &amp Co. to open the microsatellite secure (MSS) metastatic colorectal cancer m...

Spanish VC shuts $200M life sciences fund

.Spain-based Asabys Partners has actually shut a fund of 180 million euros ($ 200 thousand), money t...

BioAge introduces $198M from IPO as excessive weight biotech joins Nasdaq

.BioAge Labs is generating virtually $200 thousand by means of its Nasdaq IPO today, along with the ...

Acadia carries BMS vet on board as CEO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings...

Cassava pays $40M over apparently deceptive Alzheimer's update

.Cassava Sciences has actually consented to pay for $40 thousand to settle an investigation into ins...

Merck bags alternatives on Evaxion's AI-designed vaccination applicants

.Merck &amp Co. has picked up possibilities on pair of Evaxion Biotech injection applicants, spendin...

Enanta's RSV antiviral crushes viral load in obstacle research study

.Enanta Pharmaceuticals has connected its own respiratory syncytial virus (RSV) antiviral to conside...

Biogen containers SAGE-324 collaboration after necessary agitation fail

.Biogen has provided the last rites to its partnership along with Sage Rehabs on SAGE-324, ditching ...

AbbVie Parkinson's drug from $8.7 B Cerevel buyout scores

.On the same day that some Parkinson's disease drugs are actually being actually called into questio...